Jessi Tidwell
Nurse Practitioner · Florence, ALNPI 1013556356
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,250 of the $13,738 with a category attached, or 67.3%. AbbVie accounts for 81.0% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $11,482, more than ten times the $536 reported in 2023. Among nurse practitioner clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 192 payments — averaging $71.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$11K
- Otsuka America Pharmaceutical, Inc.$468
- Alkermes, Inc.$411
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$352
- Axsome Therapeutics, Inc.$299
- Johnson & Johnson$286
- plus $789 from 10 others
What the payments were for
- Speaking & faculty fees$9,25067%
- Travel & lodging$8466%
- Food & beverage$3,64227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $11,133 |
| Otsuka America Pharmaceutical, Inc. | 24 | $468 |
| Alkermes, Inc. | 13 | $411 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $352 |
| Axsome Therapeutics, Inc. | 12 | $299 |
| Johnson & Johnson | 10 | $286 |
| Lundbeck LLC | 15 | $283 |
| Teva Pharmaceuticals USA, Inc. | 6 | $126 |
| Corium, LLC | 11 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Neurocrine Biosciences, Inc. | 2 | $53 |
| Bioxcel Therapeutics, Inc. | 2 | $47 |
| Almatica Pharma LLC | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Indivior Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$10,269
- LYBALVI$500
- UBRELVY$118
- Auvelity$112
- REXULTI$111
- CAPLYTA$106
- ABILIFY ASIMTUFII$104
- ABILIFY MAINTENA$104
- SPRAVATO$103
How this compares
$13,738 in reported general payments places this provider in the 95th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 18 | $152 |
| Divalproex Sodium | 21 | $124 |
| Olanzapine | 16 | $94 |
| Trazodone Hcl | 12 | $34 |
| Fluoxetine Hcl | 16 | $24 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Florence
- Karen Mann-BrownFlorence$10K
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$29K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
- Ashley HodgensMontgomery$19K
- Lisa PeoplesBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.